ArticleBlood cancer journal2017

Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis.

C L Haddox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.